@ARTICLE{
author={Fleischmann Roy M,Spencer-Green George T,Fan Frank,Frankovic Biliana,Luo Xia,Hoock Thomas,Damjanov Nemanja S},
year={2011},
title={Dose Ranging Study of VX-509, An Oral Selective JAK3 Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis (RA).},
journal={ARTHRITIS AND RHEUMATISM},
volume={63},
number={12},
pages={4042-4042},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Damjanov Nemanja S,Kauffman Robert S,Spencer-Green George T},
year={2009},
title={Efficacy, Pharmacodynamics, and Safety of VX-702, a Novel p38 MAPK Inhibitor, in Rheumatoid Arthritis Results of Two Randomized, Double-Blind, Placebo-Controlled Clinical Studies},
journal={ARTHRITIS AND RHEUMATISM},
volume={60},
number={5},
pages={1232-1241},
document_type={Article},
}